Abstract | OBJECTIVES: METHODS: RESULTS: In the 50/10 OIR model compared with RA, fold changes in expression of VEGF(164), neuropilin 1, and neuropilin 2 were significantly increased at ages 14 and 18 days. A trend for increased fold change was noted in expression of VEGF receptor 2 at age 14 days and a significant increase at age 18 days in the 50/10 OIR model compared with RA. Pigment epithelium-derived factor receptor was significantly increased at age 14 days in the 50/10 OIR model compared with RA. CONCLUSION: Increased expression of VEGF(164) and angiogenic receptors were found in association with both avascular retina at day 14 and intravitreous neovascularization at day 18 in a relevant model of retinopathy of prematurity. CLINICAL RELEVANCE:
|
Authors | Steven J Budd, M Elizabeth Hartnett |
Journal | Archives of ophthalmology (Chicago, Ill. : 1960)
(Arch Ophthalmol)
Vol. 128
Issue 5
Pg. 589-95
(May 2010)
ISSN: 1538-3601 [Electronic] United States |
PMID | 20457980
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Eye Proteins
- Nerve Growth Factors
- Neuropilin-2
- RNA, Messenger
- Receptors, Neuropeptide
- Serpins
- Vascular Endothelial Growth Factor A
- pigment epithelium-derived factor
- pigment epithelium-derived factor receptor
- vascular endothelial growth factor A, rat
- Neuropilin-1
- Vascular Endothelial Growth Factor Receptor-1
- Vascular Endothelial Growth Factor Receptor-2
|
Topics |
- Animals
- Animals, Newborn
- Disease Models, Animal
- Eye Proteins
(genetics)
- Gene Expression Regulation
(physiology)
- Humans
- Infant, Newborn
- Nerve Growth Factors
(genetics)
- Neuropilin-1
(genetics)
- Neuropilin-2
(genetics)
- Polymerase Chain Reaction
- RNA, Messenger
(metabolism)
- Rats
- Rats, Sprague-Dawley
- Receptors, Neuropeptide
(genetics)
- Retinal Neovascularization
(genetics)
- Retinopathy of Prematurity
(classification, genetics)
- Serpins
(genetics)
- Vascular Endothelial Growth Factor A
(genetics)
- Vascular Endothelial Growth Factor Receptor-1
(genetics)
- Vascular Endothelial Growth Factor Receptor-2
(genetics)
- Vitreous Body
(blood supply)
|